DoD Peer Reviewed Alzheimer’s, Research Partnership Award | W81XWH 20 PRARP RPA

FAQs: DoD Peer Reviewed Alzheimer's Research Partnership Award (PRARP RPA) - W81XWH 20 PRARP RPA

What is the FY20 DoD Peer Reviewed Alzheimer's Research Partnership Award (PRARP RPA)?

The PRARP RPA (funding opportunity number W81XWH 20 PRARP RPA) is a Department of Defense (DoD) research grant/cooperative agreement administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It falls under the Science and Technology and other Research and Development category (CFDA 12.420).

When was this opportunity released and when did it close?

The listing indicates it was released in May 2020 and had an original closing date in July 2020.

Is this a discretionary funding opportunity?

Yes. The program is described as a discretionary funding opportunity.

How competitive is this award expected to be?

The listing anticipated a very limited number of awards (one expected award). That typically signals a highly competitive process focused on a small number of projects that closely match program goals.

What is the main purpose of the Partnership Award?

The central purpose is to enable true research partnerships rather than parallel or loosely connected projects. Proposals are expected to demonstrate that collaboration is essential to the design, execution, and interpretation of the research, producing outcomes that would not be achievable if investigators worked independently.

What does "true research partnership" mean in this context?

Based on the opportunity description, a true partnership means the investigators combine expertise, resources, and approaches in a way that is integral to the project. It is not enough to list multiple institutions or co-investigators; the collaboration must be necessary for the work to succeed and must strengthen the overall project beyond what each party could do alone.

What research areas does the PRARP RPA support?

The award is aligned with the mission of the Peer Reviewed Alzheimer's Research Program (PRARP), targeting Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). The description also recognizes relevant links to traumatic brain injury (TBI), and notes that teams should demonstrate experience in TBI and/or AD/ADRD research when appropriate for the proposed work.

Does the opportunity require TBI experience?

The description states that teams are expected to demonstrate experience in TBI and/or AD/ADRD research when appropriate for the proposed work. That implies TBI expertise is especially relevant when the project scope involves the AD/ADRD and TBI connection.

What types of research (basic vs applied) are allowed?

The FY20 PRARP RPA supports basic research and also accepts applications proposing preclinical or pre-validation research. This indicates the DoD is open to studies that move beyond early discovery toward feasibility, mechanistic characterization that informs development, or evidence that an approach or intervention is ready for the next stage of testing.

What is meant by "preclinical" or "pre-validation" research in this listing?

As described, this includes work intended to establish feasibility, clarify mechanisms in ways that inform downstream development, or generate evidence that a tool, approach, or intervention is positioned for subsequent testing. The emphasis is on measurable progress and reducing uncertainties that block translation.

What program priorities are highlighted besides scientific discovery?

A notable priority is the human impact described as the Overarching Challenges of Quality of Life and Family and Care Support. Applications that directly explore these challenges are encouraged, suggesting the program values research that can improve day-to-day functioning, well-being, caregiving outcomes, and support systems for individuals and families affected by AD/ADRD.

Are there restrictions on animal research for certain topics?

Yes. The description includes a strict compliance constraint: projects that address either Quality of Life or Family and Care Support are prohibited from conducting animal research.

If a project focuses on Quality of Life or Family and Care Support, what kinds of approaches are implied as acceptable?

The opportunity description suggests these projects must be built around non-animal approaches such as human-focused methods, data-driven analyses, clinical or community-based research, observational studies, caregiver interventions, health services research, or other non-animal designs that can still produce credible and actionable outcomes.

What does it mean that the award is "impact-based"?

Impact-based means applicants must articulate how the proposed work will produce meaningful outcomes tied to PRARP goals, not just interesting aims or publishable findings. The proposal is expected to connect research activities to tangible outcomes.

What outcome time horizons are applicants expected to address?

The description states proposals should address two horizons: (1) anticipated outcomes attributable to the project within the award period (short-term gains), and (2) long-term scientific gains describing how results could influence future research, follow-on development, clinical practice, caregiving support strategies, or other lasting value beyond the study.

What are examples of short-term outcomes expected within the award period?

The listing provides examples such as validated datasets, new measures, evidence supporting or refuting a mechanism, proof-of-concept results, or clear decision points that guide what the field should do next.

Who is eligible to apply?

Eligibility is listed as unrestricted, meaning the opportunity is broadly open to many entity types, subject to any clarifications that may appear in the full announcement.

What funding mechanism does this opportunity use?

The mechanism allows for either a grant or a cooperative agreement.

What is the difference between a grant and a cooperative agreement in this listing?

The description notes that cooperative agreements can involve more substantial federal involvement during the project period than traditional grants.

How much funding is available per award?

The award ceiling is listed as 0 in the summary data. This typically indicates the maximum budget was not specified in the extracted listing and would need to be confirmed in the full program announcement or related DoD guidance for that fiscal year.

Where is this opportunity administered?

It is run through the U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Department of Defense.

What does the "one expected award" detail imply for applicants?

Based on the listing alone, it implies funding was expected to support a very small number of projects, increasing the importance of tightly matching the program's partnership requirement, mission alignment (AD/ADRD and, when relevant, TBI), and the impact-based outcome expectations.

Does the partnership requirement mean multiple institutions are required?

The description does not state that multiple institutions are required, but it emphasizes that the partnership must be real and essential, not merely multiple names on paper. The key requirement presented is that collaboration is critical to the project's design and success.

Is this opportunity limited to basic science focused on biology and mechanisms?

No. While basic research is explicitly included, the opportunity also accepts preclinical or pre-validation research and encourages projects that address human-centered Overarching Challenges like Quality of Life and Family and Care Support (with the noted restriction against animal research for those themes).

What should applicants do if they need the official budget cap or other details not shown in the summary?

The listing indicates the ceiling was not specified in the extracted summary and suggests confirming the maximum budget and any additional specifics in the full program announcement or related DoD guidance for that fiscal year.